BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CHARM-EU - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CHARM-EU
X-ORIGINAL-URL:https://charm-eu.eu
X-WR-CALDESC:Events for CHARM-EU
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250218T100000
DTEND;TZID=Europe/Paris:20250218T180000
DTSTAMP:20260610T194508
CREATED:20250214T140434Z
LAST-MODIFIED:20250214T141502Z
UID:10000078-1739872800-1739901600@charm-eu.eu
SUMMARY:Farewell symposium Jan Haarhuis: Shaping the Future of Higher Education
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/farewell-symposium-jan-haarhuis-shaping-the-future-of-higher-education/
CATEGORIES:CHARM event,Governance,Innovation,Inter-Institutional Working Groups,Interculturality,Learning,Mobility,Research,Select General Information General Information,Sustainability,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250219T100000
DTEND;TZID=Europe/Paris:20250219T123000
DTSTAMP:20260610T194508
CREATED:20250114T090035Z
LAST-MODIFIED:20250114T092032Z
UID:10000072-1739959200-1739968200@charm-eu.eu
SUMMARY:Workshop: Programmatic Assessment in CHARM EU / Sinnhaft(er) prüfen – erste Schritte in Richtung Programmatic Assessment
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/workshop-programmatic-assessment-in-charm-eu-sinnhafter-prufen-erste-schritte-in-richtung-programmatic-assessment/
CATEGORIES:Learning
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250226T100000
DTEND;TZID=Europe/Paris:20250226T120000
DTSTAMP:20260610T194508
CREATED:20250114T090039Z
LAST-MODIFIED:20250218T131635Z
UID:10000073-1740564000-1740571200@charm-eu.eu
SUMMARY:Workshop: Programmatic Assessment in CHARM EU
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/workshop-programmatic-assessment-in-charm-eu/
CATEGORIES:Learning
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250325T090000
DTEND;TZID=Europe/Paris:20250327T170000
DTSTAMP:20260610T194508
CREATED:20241122T090608Z
LAST-MODIFIED:20241122T090710Z
UID:10000065-1742893200-1743094800@charm-eu.eu
SUMMARY:EU Values Compass Training
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/eu-values-compass-training/
CATEGORIES:Interculturality,Mobility,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250327
DTEND;VALUE=DATE:20250329
DTSTAMP:20260610T194508
CREATED:20250213T133518Z
LAST-MODIFIED:20250213T133518Z
UID:10000077-1743033600-1743206399@charm-eu.eu
SUMMARY:ENLIGHT Impact Conference 2025
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/enlight-impact-conference-2025/
CATEGORIES:Select General Information General Information
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250401T133000
DTEND;TZID=Europe/Paris:20250401T143000
DTSTAMP:20260610T194508
CREATED:20250307T093315Z
LAST-MODIFIED:20250307T093315Z
UID:10000079-1743514200-1743517800@charm-eu.eu
SUMMARY:LERU Talks - The European Degree: desirability\, feasibility and viability
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/leru-talks-the-european-degree-desirability-feasibility-and-viability/
CATEGORIES:Governance,Learning,Mobility
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250402
DTEND;VALUE=DATE:20250404
DTSTAMP:20260610T194508
CREATED:20250327T110352Z
LAST-MODIFIED:20250327T110352Z
UID:10000082-1743552000-1743724799@charm-eu.eu
SUMMARY:Arqus Annual Conference
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/arqus-annual-conference/
CATEGORIES:Governance,Research
ATTACH;FMTTYPE=image/jpeg:https://charm-eu.eu/wp-content/uploads/2025/03/argus-conference.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250506
DTEND;VALUE=DATE:20250508
DTSTAMP:20260610T194508
CREATED:20250311T074137Z
LAST-MODIFIED:20250311T074137Z
UID:10000080-1746489600-1746662399@charm-eu.eu
SUMMARY:CIVICA Global Forum 2025
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/civica-global-forum-2025/
CATEGORIES:Learning,Sustainability,Teaching
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2025/03/civica-global-forum-may-2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250507T103000
DTEND;TZID=Europe/Helsinki:20250507T114500
DTSTAMP:20260610T194508
CREATED:20250403T123115Z
LAST-MODIFIED:20250415T134611Z
UID:10000083-1746613800-1746618300@charm-eu.eu
SUMMARY:EUIPO Virtual Open Day for university students
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/euipo-virtual-open-day-for-university-students/
CATEGORIES:Innovation,Interculturality,Learning,Select General Information General Information
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2025/04/Virtual-Open-Day.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250509T150000
DTEND;TZID=Europe/Helsinki:20250509T160000
DTSTAMP:20260610T194508
CREATED:20250430T130729Z
LAST-MODIFIED:20250430T131009Z
UID:10000087-1746802800-1746806400@charm-eu.eu
SUMMARY:CHARM-EU Innovators’ Journey: Unlocking Innovation Through Entrepreneurship
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-innovators-journey-unlocking-innovation-through-entrepreneurship/
CATEGORIES:CHARM event,Innovation,Learning
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250519
DTEND;VALUE=DATE:20250521
DTSTAMP:20260610T194508
CREATED:20250512T075250Z
LAST-MODIFIED:20250512T121952Z
UID:10000089-1747612800-1747785599@charm-eu.eu
SUMMARY:Dissemination workshop of PATH - Planetary Health joint master’s program
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/dissemination-workshop-of-path-planetary-health-joint-masters-program/
LOCATION:online
CATEGORIES:CHARM event,Innovation,Learning,Planetary Health,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250520
DTEND;VALUE=DATE:20250522
DTSTAMP:20260610T194508
CREATED:20250318T055804Z
LAST-MODIFIED:20251002T102922Z
UID:10000081-1747699200-1747871999@charm-eu.eu
SUMMARY:Young Forum for Action on Sustainability and Climate Change
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/young-forum-for-action-on-sustainability-and-climate-change/
CATEGORIES:Sustainability
ATTACH;FMTTYPE=image/jpeg:https://charm-eu.eu/wp-content/uploads/2025/03/Design-06-768x512-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250520T133000
DTEND;TZID=Europe/Paris:20250520T173000
DTSTAMP:20260610T194508
CREATED:20250430T163429Z
LAST-MODIFIED:20250529T152313Z
UID:10000088-1747747800-1747762200@charm-eu.eu
SUMMARY:Third CHARM-EU Open Science Training
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/third-charm-eu-open-science-day/
CATEGORIES:CHARM event,Research
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250527T100000
DTEND;TZID=Europe/Helsinki:20250527T233000
DTSTAMP:20260610T194508
CREATED:20250410T130720Z
LAST-MODIFIED:20250430T131126Z
UID:10000084-1748340000-1748388600@charm-eu.eu
SUMMARY:Online World Café on Educational Research
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/online-world-cafe-on-educational-research/
CATEGORIES:Learning
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250624T090000
DTEND;TZID=Europe/Paris:20250624T170000
DTSTAMP:20260610T194508
CREATED:20250423T081026Z
LAST-MODIFIED:20250620T082005Z
UID:10000086-1750755600-1750784400@charm-eu.eu
SUMMARY:CHARM-EU International Conference "Bridging minds\, Shaping futures: Transdisciplinarity in research”
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-international-conference-bridging-minds-shaping-futures-transdisciplinarity-in-research/
LOCATION:online
CATEGORIES:Innovation,Learning
ATTACH;FMTTYPE=image/jpeg:https://charm-eu.eu/wp-content/uploads/2025/04/DoctoralSummerSchool_Confrence_Visuel-web.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250701T090000
DTEND;TZID=Europe/Paris:20250701T103000
DTSTAMP:20260610T194508
CREATED:20250620T134024Z
LAST-MODIFIED:20250620T134349Z
UID:10000090-1751360400-1751365800@charm-eu.eu
SUMMARY:Best-practice in CHARM-EU´s Hybrid Classrooms
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/best-practice-in-charm-eus-hybrid-classrooms/
LOCATION:Würzburg University\, Emil-Fischer-Straße 70\, Gebäude 70\, 97074\, Würzburg\, Germany
CATEGORIES:CHARM event,Innovation,Learning,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250714
DTEND;VALUE=DATE:20250719
DTSTAMP:20260610T194508
CREATED:20250414T103115Z
LAST-MODIFIED:20250425T065815Z
UID:10000085-1752451200-1752883199@charm-eu.eu
SUMMARY:Business & Economics Summer University at ELTE Budapest
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/business-economics-summer-university-at-elte-budapest/
CATEGORIES:Interculturality,Learning,Mobility
ATTACH;FMTTYPE=image/jpeg:https://charm-eu.eu/wp-content/uploads/2025/04/gtk-besu25-thumb.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250924T090000
DTEND;TZID=Europe/Paris:20250924T133000
DTSTAMP:20260610T194508
CREATED:20250728T074709Z
LAST-MODIFIED:20250728T125143Z
UID:10000092-1758704400-1758720600@charm-eu.eu
SUMMARY:International Conference | From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies 
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/international-conference-from-immune-activation-to-toxicity-challenges-of-cancer-immunotherapies/
LOCATION:Université de Montpelllier\, 163 rue Auguste Broussonnet\, Montpellier\, 34000\, France
CATEGORIES:CHARM event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250929
DTEND;VALUE=DATE:20250930
DTSTAMP:20260610T194508
CREATED:20250915T114115Z
LAST-MODIFIED:20251016T125117Z
UID:10000098-1759104000-1759190399@charm-eu.eu
SUMMARY:CHARM ON: Bringing Innovation into Practice
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-on-bringing-innovation-into-practice/
CATEGORIES:CHARM-EU event,Learning,Teaching
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2025/09/CHARM-ON-banner-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251001T120000
DTEND;TZID=Europe/Paris:20251001T133000
DTSTAMP:20260610T194508
CREATED:20250905T140018Z
LAST-MODIFIED:20251008T105715Z
UID:10000096-1759320000-1759325400@charm-eu.eu
SUMMARY:CHARM-EU Innovator's Journey | Building Responsible Skills for Digital and AI-Driven Entrepreneurship
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-innovators-journey-building-responsible-skills-for-digital-and-ai-driven-entrepreneurship/
LOCATION:Trinity College Dublin\, College Green\, Dublin\, Ireland
CATEGORIES:Sustainability
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251006
DTEND;VALUE=DATE:20251009
DTSTAMP:20260610T194508
CREATED:20250731T093535Z
LAST-MODIFIED:20250827T090204Z
UID:10000093-1759708800-1759967999@charm-eu.eu
SUMMARY:Cross-Border Doctorials 2025 : how to structure a research project based on European program
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/cross-border-doctorials-2025-how-to-structure-a-research-project-based-on-european-program/
CATEGORIES:Learning,Mobility
ATTACH;FMTTYPE=image/jpeg:https://charm-eu.eu/wp-content/uploads/2025/07/thumbnail_image001.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251021T150000
DTEND;TZID=Europe/Paris:20251021T171500
DTSTAMP:20260610T194508
CREATED:20250828T131008Z
LAST-MODIFIED:20251021T104933Z
UID:10000095-1761058800-1761066900@charm-eu.eu
SUMMARY:CHARM-DEN International Pitches
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-den-international-pitches-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251027T130000
DTEND;TZID=Europe/Paris:20251027T140000
DTSTAMP:20260610T194508
CREATED:20251016T132124Z
LAST-MODIFIED:20251021T110748Z
UID:10000103-1761570000-1761573600@charm-eu.eu
SUMMARY:CHARM ON #2: International Joint Programmes
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-on-2-international-joint-programmes/
CATEGORIES:CHARM-EU event,Interculturality,Learning,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251028
DTEND;VALUE=DATE:20251029
DTSTAMP:20260610T194508
CREATED:20250910T103043Z
LAST-MODIFIED:20251021T092613Z
UID:10000097-1761609600-1761695999@charm-eu.eu
SUMMARY:Designing innovative micro-credentials: Best practices and open dialogue with CHARM-EU
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/designing-innovative-micro-credentials-best-practices-and-open-dialogue-with-charm-eu/
CATEGORIES:CHARM event,CHARM-EU event,Research,Teaching
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2025/09/microcredential-event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251029T100000
DTEND;TZID=Europe/Paris:20251029T113000
DTSTAMP:20260610T194508
CREATED:20250825T114355Z
LAST-MODIFIED:20251024T122157Z
UID:10000094-1761732000-1761737400@charm-eu.eu
SUMMARY:World Café: AI for All\, Empowering European University Alliances 
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/world-cafe-ai-for-all-empowering-european-university-alliances/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251103
DTEND;VALUE=DATE:20251105
DTSTAMP:20260610T194508
CREATED:20251030T145548Z
LAST-MODIFIED:20251030T145548Z
UID:10000110-1762128000-1762300799@charm-eu.eu
SUMMARY:Democracy4All conference explores the impact of artificial intelligence on democracy
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/democracy4all-conference-explores-the-impact-of-artificial-intelligence-on-democracy/
CATEGORIES:Governance,Innovation,Planetary Health
ATTACH;FMTTYPE=image/jpeg:https://charm-eu.eu/wp-content/uploads/2025/10/creativitatdemocracy4all-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251112
DTEND;VALUE=DATE:20251113
DTSTAMP:20260610T194508
CREATED:20250624T081308Z
LAST-MODIFIED:20251110T144827Z
UID:10000091-1762905600-1762991999@charm-eu.eu
SUMMARY:CHARM-EU Annual Conference 2025
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-annual-conference-2025/
LOCATION:Bar Beton\, Pythagoraslaan 101\, Utrecht\, Netherlands
CATEGORIES:Sustainability
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2025/06/SQUARE-POST-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251124T130000
DTEND;TZID=Europe/Paris:20251124T140000
DTSTAMP:20260610T194508
CREATED:20251028T090010Z
LAST-MODIFIED:20251028T154244Z
UID:10000104-1763989200-1763992800@charm-eu.eu
SUMMARY:CHARM ON #3: Citizen Science in Action
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-on-3-citizen-science-in-action/
CATEGORIES:CHARM-EU event,Interculturality,Learning,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251127T083000
DTEND;TZID=Europe/Paris:20251127T173000
DTSTAMP:20260610T194508
CREATED:20251110T152023Z
LAST-MODIFIED:20251110T152028Z
UID:10000111-1764232200-1764264600@charm-eu.eu
SUMMARY:Closing event of the Planetary Health Joint Master’s Programme
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/closing-event-of-the-planetary-health-joint-masters-programme/
LOCATION:ELTE Faculty of Science\, 1117 Budapest Pázmány Péter sétány 1/A\, Budapest\, Hungary
CATEGORIES:Learning,Planetary Health
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251215T110000
DTEND;TZID=Europe/Paris:20251215T120000
DTSTAMP:20260610T194508
CREATED:20251204T071220Z
LAST-MODIFIED:20260106T165013Z
UID:10000112-1765796400-1765800000@charm-eu.eu
SUMMARY:Enacting Education for Sustainable Development: spotlight on teaching practices for exploring ‘Worldviews\, Perceptions and Values’.
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/enacting-education-for-sustainable-development-spotlight-on-teaching-practices-for-exploring-worldviews-perceptions-and-values/
LOCATION:online
CATEGORIES:CHARM-EU event,Interculturality,Learning,Teaching
END:VEVENT
END:VCALENDAR